Loss of RESponse to Ustekinumab Treated by Dose Escalation
Clinical trial NCT04245215 · COMPLETED
Trial details
- NCT number
- NCT04245215
- Sponsor
- Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-11
- Primary completion
- 2024-09-25
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.